Arrhythmogenic Cardiomyopathy Panel
A 22-gene panel for assessing arrhythmogenic cardiomyopathy and cardiomyopathy with arrhythmia risk, powered by the Helix Exome+® platform.
6-21 days
≤ 5 days
Panel Description
Cardiomyopathies are a broad spectrum of structural and functional disorders of the heart musculature. There are many different causes of cardiomyopathies, which range from environmental exposures to inherited genetic risk factors. In cases where an external cause is not identified, or a family history is suspicious of a hereditary risk of cardiomyopathy, diagnostic genetic testing may be ordered.
This panel evaluates 22 genes associated with arrhythmogenic cardiomyopathy, and cardiomyopathy with arrhythmia risk.
Have Questions?
Our team is available Monday through Friday, 9am-5pm Pacific Time.
Indications for Testing
A personal or family history suggestive of a hereditary form of arrhythmogenic cardiomyopathy.
Methodology
This test utilizes next-generation sequencing to detect single nucleotide variants, insertions and deletions up to 20 bp, and copy number variants in genes associated with hereditary forms of cardiomyopathies or arrhythmias.
Technical Specifications
> 99%
> 99%
> 99%
> 99%
> 90%
CDH2: Sensitivity in CDH2 exon1 may be reduced; PRKAG2: Sensitivity in PRKAG2 exon 5 may be reduced; TTN: Analysis for exons 172 to 197 will not be performed....
GRCh38
Genes Tested
Showing 22 of 22 genes in this panel